Journal article icon

Journal article

Performance of the CareStart™ G6PD deficiency screening test, a point-of-care diagnostic for primaquine therapy screening.

Abstract:

Development of reliable, easy-to-use, rapid diagnostic tests (RDTs) to detect glucose-6-phosphate dehydrogenase (G6PD) deficiency at point of care is essential to deploying primaquine therapies as part of malaria elimination strategies. We assessed a kit under research and development called CareStart™ G6PD deficiency screening test (Access Bio, New Jersey, USA) by comparing its performance to quantitative G6PD enzyme activity using a standardized spectrophotometric method ('gold standard'). ...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1371/journal.pone.0028357

Authors


More from this funder
Name:
Wellcome Trust
Funding agency for:
Baird, J
More from this funder
Name:
French Ministry of Foreign Affairs
More from this funder
Name:
WHO Regional Office for the Western Pacific
Publisher:
Public Library of Science
Journal:
PloS one More from this journal
Volume:
6
Issue:
12
Article number:
e28357
Publication date:
2011-01-01
DOI:
EISSN:
1932-6203
ISSN:
1932-6203

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP